S Pierce Selected Research

S Pierce Research Topics

Disease

8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2016 - 01/2000
6	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2016 - 03/2007
4	Leukemia 02/2016 - 02/2001
3	Neoplasms (Cancer) 04/2014 - 10/2001
3	Hematologic Neoplasms (Hematological Malignancy) 03/2007 - 03/2000
2	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 06/2014 - 03/2000
2	Contact Dermatitis (Eczema, Contact) 06/2011 - 05/2010
2	Cross Infection (Nosocomial Infection) 06/2011 - 05/2010
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2001 - 02/2000
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2000 - 02/2000
2	Disease Progression 03/2000 - 02/2000
1	Residual Neoplasm 01/2018
1	Pleural Effusion (Pleural Effusions) 07/2017
1	Dry Socket (Alveolar Osteitis) 10/2016
1	Nausea 02/2016
1	Hemorrhage 02/2016
1	Mucositis 02/2016
1	Primary Myelofibrosis (Myelosclerosis) 02/2016
1	B-Cell Lymphoma (Lymphoma, B Cell) 04/2014
1	Eczema 06/2011
1	Dermatitis 05/2010
1	Aplastic Anemia (Anemia, Hypoplastic) 07/2009
1	Acute Promyelocytic Leukemia 08/2006
1	Cerebral Hemorrhage 08/2006
1	Hypoxia (Hypoxemia) 11/2001
1	Mycoses (Diseases, Fungus) 02/2001
1	Myeloid Leukemia (Leukemia, Myelocytic) 11/2000
1	Retinoblastoma (Glioblastoma, Retinal) 11/2000
1	Cardiotoxicity 03/2000

Drug/Important Bio-Agent (IBA)

3	Decitabine FDA Link 02/2016 - 04/2014
2	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 07/2014 - 03/2000
2	Irritants (Vesicants)IBA 06/2011 - 05/2010
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 07/2009 - 08/2006
2	Dexamethasone (Maxidex)FDA LinkGeneric 02/2000 - 01/2000
2	Vincristine (Oncovin)FDA LinkGeneric 02/2000 - 01/2000
2	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2000 - 01/2000
1	Hemoglobins (Hemoglobin)IBA 07/2017
1	Oral ContraceptivesIBA 10/2016
1	CalicheamicinsIBA 02/2016
1	EpitopesIBA 02/2016
1	Pharmaceutical PreparationsIBA 02/2016
1	ChromatinIBA 02/2016
1	Gemtuzumab (Mylotarg)FDA Link 02/2016
1	Cytarabine (Cytosar-U)FDA LinkGeneric 07/2014
1	Sorafenib (BAY 43-9006)FDA Link 07/2014
1	B7-H1 AntigenIBA 06/2014
1	CTLA-4 AntigenIBA 06/2014
1	Messenger RNA (mRNA)IBA 06/2014
1	Histone Deacetylase InhibitorsIBA 04/2014
1	Proteins (Proteins, Gene)FDA Link 04/2014
1	Tyrosine (L-Tyrosine)FDA Link 04/2014
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 04/2014
1	histone H3 trimethyl Lys4IBA 11/2013
1	Toll-Like Receptors (Toll-Like Receptor)IBA 09/2013
1	Soaps (Soap)IBA 06/2011
1	EmollientsIBA 05/2010
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 07/2009
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2009
1	HLA Antigens (Human Leukocyte Antigens)IBA 03/2007
1	Protein Kinases (Protein Kinase)IBA 11/2001
1	CytokinesIBA 11/2001
1	EndotoxinsIBA 11/2001
1	JNK Mitogen-Activated Protein KinasesIBA 11/2001
1	Histidine (L-Histidine)FDA Link 10/2001
1	liposomal amphotericin B FDA Link 02/2001
1	Oncogene Proteins (Oncogene Protein)IBA 11/2000
1	Cyclin-Dependent Kinase Inhibitor p16IBA 11/2000
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 11/2000
1	Proto-Oncogene Proteins c-mdm2IBA 11/2000
1	Retinoblastoma ProteinIBA 11/2000
1	Interferon-alpha (Interferon Alfa)IBA 03/2000
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2000
1	Thrombopoietin (c-mpl Ligand)IBA 02/2000

Therapy/Procedure

8	Therapeutics 01/2018 - 02/2000
2	Hand Hygiene 06/2011 - 05/2010
1	Drug Therapy (Chemotherapy) 02/2016
1	Remission Induction 02/2014
1	Stem Cell Transplantation 04/2013
1	Blood Component Removal (Apheresis) 06/2001